JOURNAL OF INVESTIGATIVE MEDICINE, cilt.57, sa.2, ss.456-459, 2009 (SCI-Expanded)
Background: Posttransplant hyperlipidemia increases cardiovascular morbidity and mortality rate in renal transplant recipients. It also leads, to graft loss due to atherosclerosis and glomerular damage. It is essential to control hyperlipidemia in renal transplant recipients to prevent these events.